View Older Stories View More Recent Stories
-
Novo Nordisk (NVO) call put ratio 3 calls to 1 put.
-
Novo Nordisk (NVO) announces presentation of data from key semaglutide clinical trials in diabetes, obesity and chronic kidney disease
-
BofA lifts Novo Nordisk price target on EPS upside potential, upcoming pipeline data
-
Senate Panel Plans to Vote on Subpoena for Novo Nordisk (NVO) President - Bloomberg
-
Novo Nordisk (NVO) PT Raised to $160 at Argus
-
Buy the dip in this major pharma stock - Citi
-
Cabot Wealth shares top 10 stocks picks for this week
-
These 4 stocks are just added to Argus top picks list

